Intermittent inhibition of VIP-producing neurons for 16 weeks resulted in a striking reduction in liver steatosis (Figures 3A, B), suggesting that global intermittent inhibition of VIP signaling could attenuate MASLD. The gene discussed is VIP; the disease is metabolic dysfunction-associated steatotic liver disease.